Boston Scientific Announces U.S. FDA Approval Of Navigation-Enabled Ablation Catheters

Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the Rhythmia™ Mapping System.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news